View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Deals Analysis
April 21, 2020

Asia-Pacific witnesses 5.4% increase in deal activity during week ended 19 April 2020

Data and analytics company GlobalData has revealed that deal activity in the Asia-Pacific region has shown signs of revival during the week ended 19 April 2020.

Data and analytics company GlobalData has revealed that deal activity in the Asia-Pacific region has shown signs of revival during the week ended 19 April 2020.

The number of deals announced in the region increased by 5.4% during the reporting period, when compared to the earlier week.

However, an analysis of GlobalData’s Financial Deals Database revealed that the deal volume remained below the Q1 2020 and March 2020 weekly average levels.

Deal activity has remained inconsistent since the coronavirus/Covid-19 outbreak and this growth in the announcement of deals amidst the volatile market conditions is an indication of revival of optimism.

Key markets like China and Japan experienced increase in deal volume by 37% and 3.2%, respectively, during the week ended 19 April, compared to the previous week.

However, there was a decline in deal volume in South Korea and Australia by 2.6% and 38.3%, respectively.

Deal volume in healthcare (including pharmaceuticals and medical equipment) remained at the same level whereas retail sector saw decline in deal volume.

Deal activity in travel & tourism sector witnessed improvement, compared to the earlier week.

The number of private equity and venture financing deals volume increased by 14.3% and 37%, respectively, during the week compared to the previous week.

However, the volume of mergers and acquisitions and partnership deals dropped by 12.5% and 22.2%, respectively.

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU